Blocking of IL‐4/IL‐13 Signalling With Dupilumab Results in Restoration of Serum and Cutaneous Abnormalities in Netherton Syndrome

Documenti analoghi

• Langerhans cells orchestrate apoptosis of DNA‐damaged keratinocytes upon high‐dose UVB skin exposure
  di: Daniela Ortner, et al.
  Pubblicazione: (2024)
• Loss of NR2F6 Protects from Salmonella Typhimurium Infection
  di: Johannes Woelk, et al.
  Pubblicazione: (2025)
• Patients With Atopic Dermatitis Show Increased Clonal Hematopoiesis and Risk of Hematological Cancer
  di: Verena Vogi, et al.
  Pubblicazione: (2025)
• Upadacitinib shows efficacy in Netherton syndrome with poor response to Dupilumab
  di: Hui Li, et al.
  Pubblicazione: (2024)
• Dupilumab improves skin microbiome in a paediatric case of Netherton syndrome
  di: Shota Nakayama, et al.
  Pubblicazione: (2025)